From discovery to delivery, artificial intelligence is reshaping how pharma works—and the change is accelerating.
As Global Co-Host and Presenting Sponsor of Frontiers Health 2025, our team led a critical conversation on AI in pharma. With Roberto Ascione, President of Health Innovation, as moderator, we explored what it means to truly “pharmatize” AI and how the convergence of life sciences and technology is driving smarter, faster innovation.
Off the main stage, pharmaphorum captured the session’s key takeaways in an interview covering:
- Accelerating Development: How AI is speeding up drug development and clinical trials.
- Building Trust: Why transparency and governance are critical for scaling AI responsibly.
- Convergence of Industries: Life sciences, technology, and pharma coming together to redefine healthcare.
- Opportunities Ahead: From synthetic patient populations to data lineage and competitive advantage.
Explore the full pharmaphorum article and video interview here.
A perfect example of this in action? EVERSANA’s AI Agency platform—transforming pharma commercialization through a strategic collaboration with Google Cloud. Powered by Google Gemini and Vertex AI, the platform blends 80% automation with 20% human expertise from EVERSANA’s commercialization professionals, delivering revolutionary speed, precision and impact.
Learn more about the life sciences industry’s first-ever AI Agency platform
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…